Log in  First Connection?

Oncology ImagingArchives

Pleural ultrasound as an adjunct to physical examination in the preoperative evaluation of lung cancer patients

 Published on 06/02/2026 |  Original article (Full-text)  | Ismaël Bah et al. | European journal of cardio-thoracic surgery. Volume 45(5).

Preoperative evaluation of patients with suspected or confirmed lung cancer consists of clinical and radiological staging. Malignant pleural effusion is a poor prognosticator in non-small-cell lung cancer. Pleural ultrasound (PU) allows for the assessment of pleural effusion, providing real-time guidance...

Enhancing breast cancer diagnosis: non-invasive prediction of MKI-67 (Ki67) expression using ultrasound images

 Published on 30/01/2026 |  Original article (Full-text)  | Xie Hui et al. | BMC Cancer 2025; 26(1): 102

Breast cancer is one of the most common malignant tumors among women [1]. In 2020, approximately 685,000 people worldwide died from breast cancer [2]. In China, breast cancer accounts for about 10% of various malignant tumors, and the growth rate is increasing year by year, and the age of onset of patients...

Differentiating the differentiation degree of gastric cancer based on MRI radiomics

 Published on 23/01/2026 |  Original article (Full-text)  | Wang Yilin et al. | BMC Medical Imaging 2025; 26(1): 25

Gastric cancer is the fifth most common tumor with third mortality in the world. In recent decades, the incidence and mortality of gastric cancer have declined. However, due to the population growth in areas with high incidence and the improvement of diagnosis level in relevant areas, the prevalence...

Tumor shrinkage patterns and optimal timing of response assessment during neoadjuvant therapy for breast cancer: a study based on multiparametric MRI

 Published on 16/01/2026 |  Original article (Full-text)  | Wang Jingbo et al. | Cancer imaging 2025; 26(1): 2

Breast cancer is one of the most common malignancies among women. As an important therapeutic strategy, neoadjuvant systemic therapy (NST) has been widely applied in patients with locally advanced breast cancer and certain high-risk molecular subtypes [1, 2]. The primary goal of NST is to downstage the...